胃癌与BMI及糖脂代谢指标的研究进展
Research Advances on Gastric Cancer and BMI and Glucose-Lipid Metabolic Indicators
DOI: 10.12677/acm.2025.15123691, PDF,   
作者: 李 鑫：大理大学临床医学院，云南 大理；管云飞*：大理大学第一附属医院胃肠外科，云南 大理；张仁君：昆明市呈贡区斗南社区服务中心，云南 昆明
关键词: 胃癌；BMI；血脂；血糖；并发症；相关性；Gastric Cancer； BMI； Blood Lipids； Blood Glucose； Complications； Correlation
摘要: 体质量指数(body mass index, BMI)及糖脂代谢指标水平异常可影响胃癌患者手术效果、增加术后并发症的发生率，从而影响其近期疗效及预后。文章就BMI及糖脂代谢指标水平与胃癌的相关研究进展予以综述，以期为胃癌的精准治疗提供新思路，同时为胃癌与BMI及糖脂代谢指标水平相关性研究提供新的方向。
Abstract: Abnormal levels of body mass index (BMI) and glucose-lipid metabolic indicators may affect surgical outcomes in gastric cancer patients and increase the incidence of postoperative complications, thereby influencing short-term efficacy and prognosis. This article reviews the current research progress on the correlation between BMI and glucose-lipid metabolism indicators with gastric cancer, aiming to provide new insights for the precision treatment of gastric cancer and to offer new directions for studies on the relationship between gastric cancer and BMI and glucose-lipid metabolism indicators.
文章引用：李鑫, 管云飞, 张仁君. 胃癌与BMI及糖脂代谢指标的研究进展[J]. 临床医学进展, 2025, 15(12): 2580-2587. https://doi.org/10.12677/acm.2025.15123691

参考文献

[1] Lu, L., Mullins, C.S., Schafmayer, C., Zeißig, S. and Linnebacher, M. (2021) A Global Assessment of Recent Trends in Gastrointestinal Cancer and Lifestyle-Associated Risk Factors. Cancer Communications, 41, 1137-1151. [Google Scholar] [CrossRef] [PubMed]
[2] 邱玉保, 于蕾, 陈蕾, 等. 2009-2019年江苏省肿瘤登记地区胃癌发病趋势及年龄变化分析[J]. 中国肿瘤, 2024, 33(12): 961-969.
[3] Cen, X.Z., Wang, D.M., Sun, W.W., et al. (2019) The Trends of Mortality and Years of Life Lost of Cancers in Urban and Rural Areas in China, 1990‐2017. Cancer Medicine, 9, 1562-1571. [Google Scholar] [CrossRef] [PubMed]
[4] 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会胃癌临床诊疗指南(2021版) [J]. 中华医学杂志, 2022(16): 1169-1189.
[5] Feng, R.M., Zong, Y.N., Cao, S.M. and Xu, R.H. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statistics? Cancer Communications, 39, 1-12. [Google Scholar] [CrossRef] [PubMed]
[6] 易颜琳, 张学云, 郑松柏. 我国胃癌流行病学变迁和启示[J]. 胃肠病学, 2021, 26(8): 489-493.
[7] 王培宇, 黄祺, 王少东, 等. 《全球癌症统计数据2022》要点解读[J]. 中国胸心血管外科临床杂志, 2024, 31(7): 933-954.
[8] Kulig, J., Sierzega, M., Kolodziejczyk, P., Dadan, J., Drews, M., Fraczek, M., et al. (2010) Implications of Overweight in Gastric Cancer: A Multicenter Study in a Western Patient Population. European Journal of Surgical Oncology, 36, 969-976. [Google Scholar] [CrossRef] [PubMed]
[9] 王潇荷, 阎涵, 井丽, 等. 辽宁省40岁及以上居民中国内脏脂肪指数与糖尿病患病风险相关性分析[J/OL]. 中国全科医学, 1-8.
https://link.cnki.net/urlid/13.1222.r.20251205.1343.002, 2025-12-05.
[10] 李博斐. 低体重指数是胃癌患者的不良预后因素——基于2029例中国单中心大样本的研究[J]. 临床与病理杂志, 2015(z1): 32-33.
[11] Lee, H.H., Park, J.M., Song, K.Y., Choi, M. and Park, C.H. (2016) Survival Impact of Postoperative Body Mass Index in Gastric Cancer Patients Undergoing Gastrectomy. European Journal of Cancer, 52, 129-137. [Google Scholar] [CrossRef] [PubMed]
[12] Taniguchi, Y., Kurokawa, Y., Hagi, T., Takahashi, T., Miyazaki, Y., Tanaka, K., et al. (2019) Methylprednisolone Inhibits Tumor Growth and Peritoneal Seeding Induced by Surgical Stress and Postoperative Complications. Annals of Surgical Oncology, 26, 2831-2838. [Google Scholar] [CrossRef] [PubMed]
[13] Kehlet, H. (2006) Labat Lecture 2005: Surgical Stress and Postoperative Outcome—From Here to Where? Regional Anesthesia & Pain Medicine, 31, 47-52.
[14] Wu, X.S., Wu, W.G., Li, M.L., et al. (2013) Impact of Being Overweight on the Surgical Outcomes of Patients with Gastric Cancer: A Meta-Analysis. World Journal of Gastroenterology, 19, 4596-4606. [Google Scholar] [CrossRef] [PubMed]
[15] Deng, J., Liang, H., Wang, D., Sun, D., Ding, X., Pan, Y., et al. (2009) Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio between Positive and Examined Lymph Nodes. Annals of Surgical Oncology, 17, 1043-1051. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, J.H., Chin, H.M., Hwang, S.S. and Jun, K.H. (2014) Impact of Intra-Abdominal Fat on Surgical Outcome and Overall Survival of Patients with Gastric Cancer. International Journal of Surgery, 12, 346-352. [Google Scholar] [CrossRef] [PubMed]
[17] Wong, J., Rahman, S., Saeed, N., Lin, H., Almhanna, K., Shridhar, R., et al. (2014) Effect of Body Mass Index in Patients Undergoing Resection for Gastric Cancer: A Single Center US Experience. Journal of Gastrointestinal Surgery, 18, 505-511. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, H.N., Chen, X.Z., Zhang, W.H., et al. (2015) The Impact of Body Mass Index on the Surgical Outcomes of Patients with Gastric Cancer: A 10-Year, Single-Institution Cohort Study. Medicine, 94, e1769. [Google Scholar] [CrossRef] [PubMed]
[19] Sugimoto, M., Kinoshita, T., Shibasaki, H., Kato, Y., Gotohda, N., Takahashi, S., et al. (2013) Short-Term Outcome of Total Laparoscopic Distal Gastrectomy for Overweight and Obese Patients with Gastric Cancer. Surgical Endoscopy, 27, 4291-4296. [Google Scholar] [CrossRef] [PubMed]
[20] Kastelein, J.J.P., Akdim, F., Stroes, E.S.G., Zwinderman, A.H., Bots, M.L., Stalenhoef, A.F.H., et al. (2008) Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. New England Journal of Medicine, 358, 1431-1443. [Google Scholar] [CrossRef] [PubMed]
[21] 朱洁琳, 黄卫权. 阿尔茨海默病患者血脂水平与正常人的比较分析[J]. 实验与检验医学, 2012, 30(5): 521-522.
[22] Butler, L.M., Perone, Y., Dehairs, J., Lupien, L.E., de Laat, V., Talebi, A., et al. (2020) Lipids and Cancer: Emerging Roles in Pathogenesis, Diagnosis and Therapeutic Intervention. Advanced Drug Delivery Reviews, 159, 245-293. [Google Scholar] [CrossRef] [PubMed]
[23] 李彦庆, 王亮, 符谨诚, 等. 胃癌与血脂及脂蛋白的相关性研究进展[J]. 疑难病杂志, 2024, 23(7): 879-882.
[24] 徐泳, 姜大勇, 毛志华. 血脂、胰岛素和C-反应蛋白水平评价胃癌严重程度和预测复发的临床价值[J]. 实验与检验医学, 2014, 32(5): 608-610.
[25] 姬薇. 血脂水平与可切除胃癌患者病理学特征及预后的相关性分析[D]: [硕士学位论文]. 兰州: 兰州大学, 2023.
[26] 郭芝妤, 曹田宇, 王伟东, 等. 胃癌手术患者血脂水平与生存预后的相关性: 一项回顾性队列研究[J]. 中国癌症防治杂志, 2024, 16(6): 687-693.
[27] Chang, W.C., Huang, S.F., Lee, Y.M., et al. (2017) Cholesterol Import and Steroidogenesis Are Biosignatures for Gastric Cancer Patient Survival. Oncotarget, 8, 692-704. [Google Scholar] [CrossRef] [PubMed]
[28] Hong, S.H., Noh, E., Kim, J., et al. (2020) Fasting Plasma Glucose Variability and Gastric Cancer Risk in Individuals without Diabetes Mellitus: A Nationwide Population-Based Cohort Study. Clinical and Translational Gastroenterology, 11, e00221. [Google Scholar] [CrossRef] [PubMed]
[29] 张艳, 王丹丹, 李宏丽, 窦彩玲, 刘洁, 鲍亚丽. 缩短术前禁食水时间对胃癌患者术后胰岛素抵抗的影响[J]. 中国临床研究, 2019, 32(1): 130-132.
[30] 李薇, 盛时运, 李子昱, 等. 国医大师李佃贵从脾虚论治胃癌术后常见症状经验[J] . 江苏中医药, 2024, 56(11) : 8-11.
[31] 张华锋. 胃黏液腺癌术后精囊转移1例[J]. 中国乡村医药, 2024, 31(21): 45-46.
[32] 张静, 曾星, 王先瑜. 营养风险指数与老年胃癌根治术后肌少症的相关性分析[J]. 中华保健医学杂志, 2024, 26(5): 593-596.
[33] Davis, G., Fayfman, M., Reyes-Umpierrez, D., Hafeez, S., Pasquel, F.J., Vellanki, P., et al. (2018) Stress Hyperglycemia in General Surgery: Why Should We Care? Journal of Diabetes and Its Complications, 32, 305-309. [Google Scholar] [CrossRef] [PubMed]
[34] Fiorillo, C., Quero, G., Laterza, V., Mascagni, P., Longo, F., Menghi, R., et al. (2020) Postoperative Hyperglycemia Affects Survival after Gastrectomy for Cancer: A Single-Center Analysis Using Propensity Score Matching. Surgery, 167, 815-820. [Google Scholar] [CrossRef] [PubMed]
[35] Vedantam, D., Poman, D.S., Motwani, L., et al. (2020) Stress-Induced Hyperglycemia: Consequences and Management. Cureus, 14, e26714.
[36] Kotagal, M., Symons, R.G., Hirsch, I.B., Umpierrez, G.E., Dellinger, E.P., Farrokhi, E.T., et al. (2015) Perioperative Hyperglycemia and Risk of Adverse Events among Patients with and without Diabetes. Annals of Surgery, 261, 97-103. [Google Scholar] [CrossRef] [PubMed]
[37] 黄金, 姚慧. 围术期患者血糖监测现状调查[J]. 护理学杂志, 2011, 26(2): 22-23.
[38] Zhao, X., Zou, J.X., Wang, Z.W., et al. (2021) Identifying Novel Cell Glycolysis‐Related Gene Signature Predictive of Overall Survival in Gastric Cancer. BioMed Research International, 2021, Article 9656947. [Google Scholar] [CrossRef] [PubMed]
[39] Wu, J.P., Yang, Y.F., Cheng, L., et al. (2021) GC Discrimination: Identification of Gastric Cancer Based on a Milliliter of Blood. Briefings in Bioinformatics, 22, 536-544. [Google Scholar] [CrossRef] [PubMed]
[40] Ran, T., Chen, Z., Zhao, L., Ran, W., Fan, J., Hong, S., et al. (2021) LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer. Technology in Cancer Research & Treatment, 20, Article 15330338211004944. [Google Scholar] [CrossRef] [PubMed]
[41] Hu, Y.Y., Chen, X.Q., Hendi, M., et al. (2021) Diagnostic Ability of Magnifying Narrow-Band Imaging for the Extent of Early Gastric Cancer: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice, 2021, 1-9. [Google Scholar] [CrossRef] [PubMed]
[42] Liu, Y., Wang, H., Chen, X., et al. (2023) Dynamic Changes in Red Blood Cell Distribution Width Predict Chemotherapy Response in Advanced Gastric Cancer: A Multicenter Prospective Study. Journal of Hematology & Oncology, 16, 45.
[43] Farag, C.M., Antar, R., Akosman, S., Ng, M. and Whalen, M.J. (2023) Addendum: What Is Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score? A Comprehensive Literature Review of Halp’s Prognostic Ability in Different Cancer Types. Oncotarget, 14, 748-748. [Google Scholar] [CrossRef] [PubMed]
[44] Li, S.P., Lu, Z.F., Wu, S.Y., et al. (2024) The Dynamic Role of Platelets in Cancer Progression and Their Therapeutic Implications. Nature Reviews Cancer, 24, 72-87. [Google Scholar] [CrossRef] [PubMed]
[45] 谢桂生, 韦皓棠, 陈丰, 等. 高体质指数对胃癌切除术患者预后影响的Meta分析[J]. 中国癌症防治杂志, 2019, 11(3): 245-251.

为你推荐